Compare Stocks: NUWE, MBAI, NDRA, and ICCM

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ICCM IceCure Medical	$2.23 +1.4%	$3.24	$2.12 ▼ $42.00	$7.54M	0.45	155,797 shs	58,363 shs
MBAI Check-Cap	$6.50	$7.82	$4.41 ▼ $27.44	$8.94M	0.67	28,417 shs	21,150 shs
NDRA ENDRA Life Sciences	$6.05 +6.5%	$4.93	$2.96 ▼ $9.85	$8.52M	-0.05	41,006 shs	20,582 shs
NUWE Nuwellis	$0.78 +6.3%	$2.01	$0.71 ▼ $183.05	$2.68M	0.23	1.73 million shs	222,226 shs

Don't Wait for the OpenAI IPO

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ICCM IceCure Medical	+1.36%	-3.04%	-30.53%	-48.85%	-92.92%
MBAI Check-Cap	0.00%	-1.22%	-28.57%	-32.71%	+649,999,900.00%
NDRA ENDRA Life Sciences	+6.51%	+20.76%	+33.26%	+43.03%	+37.81%
NUWE Nuwellis	+6.29%	-12.15%	-54.33%	-86.66%	-99.55%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ICCM IceCure Medical	$2.23 +1.4%	$3.24	$2.12 ▼ $42.00	$7.54M	0.45	155,797 shs	58,363 shs
MBAI Check-Cap	$6.50	$7.82	$4.41 ▼ $27.44	$8.94M	0.67	28,417 shs	21,150 shs
NDRA ENDRA Life Sciences	$6.05 +6.5%	$4.93	$2.96 ▼ $9.85	$8.52M	-0.05	41,006 shs	20,582 shs
NUWE Nuwellis	$0.78 +6.3%	$2.01	$0.71 ▼ $183.05	$2.68M	0.23	1.73 million shs	222,226 shs

Don't Wait for the OpenAI IPO

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ICCM IceCure Medical	+1.36%	-3.04%	-30.53%	-48.85%	-92.92%
MBAI Check-Cap	0.00%	-1.22%	-28.57%	-32.71%	+649,999,900.00%
NDRA ENDRA Life Sciences	+6.51%	+20.76%	+33.26%	+43.03%	+37.81%
NUWE Nuwellis	+6.29%	-12.15%	-54.33%	-86.66%	-99.55%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ICCM IceCure Medical	2.20	Hold	$52.50	2,254.26% Upside
MBAI Check-Cap	1.00	Sell	N/A	N/A
NDRA ENDRA Life Sciences	2.00	Hold	$25.00	313.22% Upside
NUWE Nuwellis	1.00	Sell	N/A	N/A

Current Analyst Ratings Breakdown

Latest NUWE, MBAI, NDRA, and ICCM Analyst Ratings

Date	Company	Brokerage	Action	Rating
8/14/2026	ICCM IceCure Medical	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Hold ➝ Strong Sell
8/13/2026	NDRA ENDRA Life Sciences	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
7/31/2026	NDRA ENDRA Life Sciences	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
7/21/2026	MBAI Check-Cap	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D-)
7/17/2026	ICCM IceCure Medical	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)
7/17/2026	NDRA ENDRA Life Sciences	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)
6/24/2026	NUWE Nuwellis	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)

(Data available from 9/5/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ICCM IceCure Medical	$3.38M	2.26	N/A	N/A	$3.47 per share	0.64
MBAI Check-Cap	N/A	N/A	$3.96 per share	1.64	$3.30 per share	N/A
NDRA ENDRA Life Sciences	N/A	N/A	N/A	N/A	$4.21 per share	N/A
NUWE Nuwellis	$8.27M	0.34	N/A	N/A	($0.56) per share	-1.39

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ICCM IceCure Medical	-$15.06M	-$8.52	N/A	N/A	N/A	-427.67%	-174.26%	-112.58%	11/18/2026 (Estimated)
MBAI Check-Cap	$4.14M	-$14.07	N/A	N/A	N/A	N/A	N/A	N/A	N/A
NDRA ENDRA Life Sciences	-$7.03M	-$6.38	N/A	N/A	N/A	N/A	-246.34%	-150.81%	11/13/2026 (Estimated)
NUWE Nuwellis	-$17.52M	-$132.59	N/A	N/A	N/A	-123.38%	-623.14%	-147.34%	11/11/2026 (Estimated)

Latest NUWE, MBAI, NDRA, and ICCM Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/14/2026	Q2 2026	NDRA ENDRA Life Sciences	-$0.84	-$0.63	+$0.21	$0.06	$0.10 million	N/A
8/13/2026	Q2 2026	NUWE Nuwellis	-$23.80	-$26.64	-$2.84	-$26.64	$2.42 million	$1.97 million
6/30/2026	Q2 2026	ICCM IceCure Medical	N/A	-$1.60	N/A	-$1.5970	N/A	$0.91 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
ICCM IceCure Medical	N/A	N/A	N/A	N/A	N/A
MBAI Check-Cap	N/A	N/A	N/A	N/A	N/A
NDRA ENDRA Life Sciences	N/A	N/A	N/A	N/A	N/A
NUWE Nuwellis	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ICCM IceCure Medical	N/A	2.88	2.44
MBAI Check-Cap	N/A	0.05	0.05
NDRA ENDRA Life Sciences	N/A	7.10	7.10
NUWE Nuwellis	N/A	1.97	1.54

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ICCM IceCure Medical	0.62%
MBAI Check-Cap	1.07%
NDRA ENDRA Life Sciences	1.19%
NUWE Nuwellis	3.13%

Insider Ownership

Company	Insider Ownership
ICCM IceCure Medical	2.44%
MBAI Check-Cap	0.48%
NDRA ENDRA Life Sciences	10.00%
NUWE Nuwellis	1.60%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ICCM IceCure Medical	60	3.43 million	3.34 million	Not Optionable
MBAI Check-Cap	80	1.38 million	1.37 million	N/A
NDRA ENDRA Life Sciences	20	1.50 million	1.35 million	Not Optionable
NUWE Nuwellis	70	3.65 million	3.59 million	Not Optionable

NUWE, MBAI, NDRA, and ICCM Headlines

Recent News About These Companies

Nuwellis Highlights Aquadex Growth in Updated Presentation

August 27, 2026 | theglobeandmail.com

Nuwellis Expands Critical Care Portfolio Through Strategic Commercial Agreement with Atrility Medical

August 25, 2026 | globenewswire.com

Nuwellis Inc (NUWE) (Q2 2026) Earnings Call Highlights: Revenue Surges 14% and Installed Base ...

August 14, 2026 | finance.yahoo.com

Nuwellis, Inc. (NUWE) Q2 2026 Earnings Call Prepared Remarks Transcript

August 13, 2026 | seekingalpha.com

Nuwellis Reports Second Quarter 2026 Financial Results and Business Highlights Focused on Double Digit Revenue Growth and Expanded Gross Margin

August 13, 2026 | globenewswire.com

Nuwellis Accelerates Digital Transformation of the Aquadex® Platform with EHR Connectivity and Enhanced User Interface

August 11, 2026 | finance.yahoo.com

Nuwellis Strengthens Product Development Organization with Appointment of Dale Brady as Principal R&D Engineer

August 6, 2026 | globenewswire.com

Nuwellis Announces Next-Generation Aquadex Platform Strategy to Expand Future Critical Care Applications

August 4, 2026 | globenewswire.com

Nuwellis Slumps on Share Sale

July 31, 2026 | baystreet.ca

Nuwellis Prices $3.4 Million Direct Offering, Receives Warrant Proceeds

July 31, 2026 | finance.yahoo.com

Nuwellis announces pricing of $3.4M registered direct offering priced at-the-market under Nasdaq rules

July 31, 2026 | seekingalpha.com

Nuwellis Announces Pricing of $3.4 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

July 31, 2026 | globenewswire.com

Nuwellis Announces Acceptance by Frontiers in Pediatrics of New Single-Center Retrospective Study Supporting Alternative Anticoagulation Strategy for Aquadex Ultrafiltration ...

July 30, 2026 | markets.businessinsider.com

Nuwellis Stock Explodes Thursday: What's Driving the Action?

July 30, 2026 | benzinga.com

Nuwellis Announces Acceptance by Frontiers in Pediatrics of New Single-Center Retrospective Study Supporting Alternative Anticoagulation Strategy for Aquadex Ultrafiltration Therapy

July 30, 2026 | globenewswire.com

Nuwellis (NUWE) stock rallies 90% after hours: Here's why It is trending

July 30, 2026 | msn.com

Nuwellis Expands Wisconsin Pediatric Footprint With Aquadex SmartFlow System

July 29, 2026 | finance.yahoo.com

Nuwellis Expands Pediatric Footprint with First Aquadex SmartFlow® Installations in Wisconsin

July 28, 2026 | markets.businessinsider.com

Nuwellis’ new CEO on building a strong foundation for sustainable value creation

July 27, 2026 | finance.yahoo.com

Nuwellis Announces Preliminary Revenue Results for the Second Quarter 2026 Showing Double Digit Growth

July 27, 2026 | globenewswire.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

NUWE, MBAI, NDRA, and ICCM Company Descriptions

IceCure Medical NASDAQ:ICCM

$2.23 +0.03 (+1.36%)

As of 09/4/2026 04:00 PM Eastern

IceCure Medical Ltd, a commercial stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors. The company offers ProSense system, a single probe system for the treatment of tumors, as well as associated disposables; and IceSense3 system for ablation indications to urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology. It also develops XSense system, a single probe system; and MultiSense, a multi probe system for the treatment of multiple and larger tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.

Check-Cap NASDAQ:MBAI

$6.50 0.00 (0.00%)

As of 09/4/2026 04:00 PM Eastern

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. The company was incorporated in 2004 and is based in Isfiya, Israel.

ENDRA Life Sciences NASDAQ:NDRA

$6.05 +0.37 (+6.51%)

As of 09/4/2026 04:00 PM Eastern

ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is developing thermo-acoustic enhanced ultrasound technology that uses radio frequency pulses to generate ultrasonic waves in tissue to create high-contrast images for use in the treatment of nonalcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion. It has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.

Nuwellis NASDAQ:NUWE

$0.78 +0.05 (+6.29%)

As of 09/4/2026 04:00 PM Eastern

Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company offers Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through independent specialty distributors in Austria, Belarus, Brazil, Colombia, the Czech Republic, Germany, Greece, Hong Kong, India, Israel, Italy, Panama, Romania, Singapore, Slovakia, Spain, Switzerland, Thailand, the United Arab Emirates, and the United Kingdom. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest NUWE, MBAI, NDRA, and ICCM Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest NUWE, MBAI, NDRA, and ICCM Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

NUWE, MBAI, NDRA, and ICCM Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

NUWE, MBAI, NDRA, and ICCM Company Descriptions

IceCure Medical NASDAQ:ICCM

Check-Cap NASDAQ:MBAI

ENDRA Life Sciences NASDAQ:NDRA

Nuwellis NASDAQ:NUWE

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest NUWE, MBAI, NDRA, and ICCM Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest NUWE, MBAI, NDRA, and ICCM Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

NUWE, MBAI, NDRA, and ICCM Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

NUWE, MBAI, NDRA, and ICCM Company Descriptions

IceCure Medical NASDAQ:ICCM

Check-Cap NASDAQ:MBAI

ENDRA Life Sciences NASDAQ:NDRA

Nuwellis NASDAQ:NUWE

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools